The purpose of this study is to test the effectiveness of a 6-week course of in-home telerehabilitation in individuals following their stroke.

The purpose of this research study is to investigate the investigational drug ACP-204's safety, efficacy, and pharmacokinetics (the movement of the study drug into, through, and out of the body and what the body does to the study drug) as treatment for Lewy Body Dementia Psychosis (LBDP) as compared with placebo (sugar pill).

The purpose of our research is to collect catastrophic sports injury and illness data from athletics competing in competitive organized sports on a national level. Analysis of this data is intended to reduce the risk of catastrophic injury and illness and increase safety of sport participation.

The purpose of this research study is to develop the Alzheimer's Disease and Related Dementias Palliative Care (ADRD-PC) program for persons with late-stage ADRD and their family members during a hospitalization. For patients, we aim to learn if this program of dementia-specific palliative is effective to reduce hospital transfers, improve symptom treatment, supplement supportive services and reduce nursing home transitions. For family members, we aim to improve communication with clinicians, shared decision-making and decrease distress.

The purpose of this study is to determine how effortful someone thinks stepping over an obstacle is. We will try to relate this sense of effort to the way that they move.

The purpose of this research is to understand how head hits in ice hockey influence brain health and to understand ways to improve safety in ice hockey.

To monitor incidence of probable and confirmed meningitis in children receiving the RTS,S/AS01 malaria vaccine in Malawi.

This study will collect information about children who have rare types of lung disease to help us understand how better to diagnose and treat these patients. Information will be collected from participants' doctors about how different aspects of their disease and treatment. This will be compared to information from other such patients from other hospitals around the United States. By gathering information on many such patients, we hope to develop best practices for such patients. These may lead to new research studies, which we can invite participants in this study to consider as well.

This is a study being conducted at many sites across the US to evaluate patients who are older than 50 years old, who have sudden bleeding in the brain (intracerebral hemorrhage) while taking a statin medication. It is unclear if continuing to take a statin medication after this type of injury can increase the risk of another hemorrhage, stroke or cardiac event. This study will assign patients to 1 of 2 groups. One group will continue the statin medication they were taking previously. The other group will discontinue the statin medication. Both groups will be followed for 2 years to see if they have any additional medical events.

The purpose of this study is to assess the efficacy of BHV-7000 over the course of a 104 week trial with a two-week follow up phase totalling 106 weeks. Individuals must have been enrolled in the parent BHV-7000-303 study to qualify for this study.